Supreme Court Rejects Major Humira Lawsuit Involving Patents

In a recent landmark decision, the Supreme Court refused to hear a claim from pharmaceutical giant Johnson and Johnson alleging that a rival company stole its drug technology.  Johnson & Johnson originally sued Abbott Laboratories for $1.67 billion, saying that Abbott infringed on its Humira patents. Humira, with sales of nearly $8 billion last year, is Abbott’s best-selling drug. The controversial medication is used to treat a variety of conditions, including Crohn’s disease and rheumatoid arthritis. While we’ll never know for sure Continue reading

Memphis Man Sues Abbott, Saying Humira Caused Histoplasmosis

  [CAPTION: Fred Delano says Humira weakened his immune system, therefore leaving him vulnerable to histoplasmosis. (Photo Courtesy of the Memphis Flyer)] For people living in the Mississippi River Valley, histoplasmosis remains a fairly serious threat. Histoplasmosis is a fungal infection spread by airborne spores. It’s especially prevalent in places with bird droppings, such as bat caves and chicken coops. Though Fred Delano worked in an advertising agency, he claims he contracted histoplasmosis as a result of taking the Abbott Continue reading

Multiple Lawsuits Claim Abbott’s Humira Caused Vision Loss & Neurological Injury

Two separate lawsuits are alleging that Abbott Laboratories’ best-selling Humira drug, used to treat Crohn’s disease, caused lasting nerve damage in patients’ feet and eyes. The first lawsuit, filed in April by Kara Mae Pletan of Montana, claims that Humira was responsible for “stabbing pains and hypersensitivity” in her feet. “The progression of the nerve damage seems to have stopped [after ceasing Humira injections],” Pletan said in court documents. “But the nerve damage appears to be permanent.” According to the Humira lawsuit papers, Continue reading

FDA Issues Warning About Humira, Saying Drug May Pose Cancer Risk to Teens

A recent warning issued on the FDA’s Web site says Humira, a drug used to treat Crohn’s disease and other inflammatory bowel diseases, may put teens at risk for developing cancer.   “The FDA continues to receive reports of a rare cancer of white blood cells, primarily in adolescents and young adults being treated for Crohn’s disease and ulcerative colitis, with medicines known as tumor necrosis factor (TNF) blockers,” the FDA said in its statement. “[We] believe the risks and benefits of using TNF blockers...should be carefully weighed when Continue reading

Multiple Lawsuits Claim Abbott’s Humira Caused Permanent Nerve Damage

  Two separate lawsuits are alleging that Abbott Laboratories’ best-selling Humira drug, used to treat a variety of medical conditions including arthritis and Crohn’s disease, caused lasting nerve damage in patients’ feet, eyes--- and complete neurological system.     The first lawsuit, filed in April by Kara Mae Pletan of Montana, claims that Humira was responsible for “stabbing pains and hypersensitivity” in her feet. “The progression of the nerve damage seems to have stopped [after ceasing Humira injections],” Pletan said Continue reading

Research Supports The Connection Between Humira Usage And Development Of Cancer In Children

I recently met with a family who's teenage daughter developed multiple lesions on her lungs and significant vision loss after taking Humira for treatment of her Crohn's Disease. Turns out, her situation is not unique. A substantial number of children, teens and adults who have taken Humira for various types of arthritis and other types of inflammatory conditions have now developed cancer and other debilitating neurological complications within several years of their usage. Lawyers are currently investigating how much knowledge Humira's Continue reading